Annals of Medicine
All the Carcinogens We Cannot See
We routinely test for chemicals that cause mutations. What about the dark matter of carcinogens—substances that don’t create cancer cells but rouse them from their slumber?
By Siddhartha Mukherjee
A New Approach to M.S. Could Transform Treatment of Other Diseases
Multiple sclerosis was once seen as a “dead-end disease.” But lots of little interventions have added up to remarkable progress. Should that change how we take on other conditions?
By Rivka Galchen
The Medical Miracle of a Pig’s Heart in a Human Body
The first successful transplantation may solve a donor shortage, but this major scientific advancement is not without challenges.
By Rivka Galchen
The Struggle to Define Long COVID
Patients and skeptics are squaring off. Can research heal the rift?
By Dhruv Khullar
Costa Ricans Live Longer Than We Do. What’s the Secret?
We’ve starved our public-health sector. The Costa Rica model demonstrates what happens when you put it first.
By Atul Gawande
Do Brain Implants Change Your Identity?
As neural devices proliferate, so do reports of personality changes, foundering relationships, and people who want to leave their careers.
By Christine Kenneally
When a Virus Is the Cure
As bacteria grow more resistant to antibiotics, bacteriophage therapy is making a comeback.
By Nicola Twilley
The Promise and the Peril of Virtual Health Care
During the coronavirus pandemic, telemedicine looks like the future of health care. Is it a future that we want?
By John Seabrook
Why Weren’t We Ready for the Coronavirus?
The U.S. has fared worse than other countries not because it lacked information or funding but because it failed to learn the lessons of the last outbreaks.
By David Quammen
How Anthony Fauci Became America’s Doctor
An infectious-disease expert’s long crusade against some of humanity’s most virulent threats.
By Michael Specter